Seems we are now overdue for some key announcements, and the recent one's were all out of left field but hugely accretive for our company!!
1. St.Jude on DIPG is on the timeline for July/August - overdue
2. Dana-Faber on Brain Mets looks like August/September - any day now
3. Our long, lost friend Cantrixil due Aug/Sept as well - any day now
4. Further update on GBM PII Q4...
Had thought of selling out to try to 'catch the knife', but not a chance with the above potential company making announcements!!! If any of 1, 2 & 4 are positive then our potential market size for paxalisib will multiply the conservative USD1 - 1.5 billion!
- Forums
- ASX - By Stock
- KZA
- Ann: Kazia's paxalisib granted Fast Track Designation by FDA
Ann: Kazia's paxalisib granted Fast Track Designation by FDA, page-62
-
- There are more pages in this discussion • 5 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add KZA (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
LU7
LITHIUM UNIVERSE LIMITED
Alex Hanly, CEO
Alex Hanly
CEO
Previous Video
Next Video
SPONSORED BY The Market Online